<DOC>
	<DOCNO>NCT00779779</DOCNO>
	<brief_summary>This Post Marketing Surveillance ( PMS ) collect reactogenicity safety data use human rotavirus vaccine healthy infant age 6 week ( first dose ) 24 week ( second dose ) .</brief_summary>
	<brief_title>Evaluation Reactogenicity Safety GSK Biologicals ' Rotarixâ„¢ ( Human Rotavirus Vaccine ) Infants</brief_title>
	<detailed_description />
	<mesh_term>Gastroenteritis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subjects investigator believe parents/guardians comply requirement protocol . A male female least 6 week age time first vaccination . Written inform consent obtain parent guardian subject . History allergic disease reaction likely exacerbate component vaccine . Acute disease time enrolment . Any history uncorrected congenital malformation gastrointestinal tract would predispose intussusception . Any contraindication state updated approve Prescribing Information</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>19 Weeks</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Gastroenteritis</keyword>
</DOC>